thanks for the info and research. will load them up and wait
I have been trading close to FDA approval date and so far (knock on wood) so good. But I have noticed the skilled traders are making 800% to 1000% profit (vs. 50% to 200%) because they got in earlier. Lately I realised that much of the 800%-1000% profit can be captured before a company announce its Phase III Top Line results. So I did a little researching and DD...below are a list of short term plays recommended for those of you who share my greedy mantality:
AEZS - Phase III result reporting 3Q2009
ACAD - Phase III Top Line reporting by 3Q2009 (this one already popped)
ARNA - Phase III Top Line by end of September 2009, NDA Dec09
AVNR - Phase III Top Line report by September 2009
CHTP - Phase III Top Line 3Q2009, NDA 4Q2009
JAV - Phase III Top Line Mid 2009, NDA Late 2009 (in play recently)
GNVC - Phase III result reporting early 2010 (still cheap)
GTXI - Phase III Top Line late summer 2009 (also has approval date 10/30/09)
Good luck to all and please pay it forward! Comments welcome, thanks.
Last edited by Lucifer; 07-28-2009 at 01:51 PM. Reason: spelling
thanks for the info and research. will load them up and wait
Thanks for the Hardwork and putting togather. All of these are strong buy recomendation.
Thanks for this Lucifer!
Although noticing most of the comps here are already relatively developed with significant market caps... I'm new to pharma trading myself, but seems like if you want 1000% gains you need to target companies when they are still OTC trading in the sub-dollar ranges.
for instance Acadia (been watching this one, but missed out on the major jump yesterday) is already up 400% this year mostly in two major gaps (100%+ in a single day), but hey that doesn't mean they can't go up another 400%
thx again
thanks for the list, Lucifer !!
thanks for the list and your hard work!
Good luck to you as well
Good job. Thanks for sharing.
thanks for the update
GTXI is too expensive now
check out ARIA - great oncology drugs in the pipeline/phase 3